# Propanc Biopharma, Inc.: Form 8-K, filed Nov 19, 2020

- Company: [Propanc Biopharma, Inc.](/companies/ppcb.md) (CIK 1517681)
- Form: 8-K
- Filed: 2020-11-19
- Accepted by EDGAR: Nov 19, 2020, 10:41 ET
- Period: 2020-11-17
- Accession: 0001493152-20-022006
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1517681/000149315220022006/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1517681/000149315220022006/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1517681/000149315220022006/form8-k.htm

Filed Nov 19, 2020.
Source: SEC EDGAR, the filing index for accession 0001493152-20-022006. Last ingested by Listed: Oct 29, 2026, 17:01 ET. No prices; not investment advice.